Industry News

Industry News

New 'whole-body scan' could improve bone marrow cancer treatment

Jan 29, 2014

Developments in magnetic resonance imaging have led to a pioneering new technique that scans the patient's entire body. This new kind of scan could be useful for showing doctors where a patient's bones may be affected by cancer.Magnetic resonance imaging - or MRI - is an imaging test that uses magnets and radio waves to create pictures of the body. Read More

Compounds in exhaled breath may identify early lung cancer

Jan 28, 2014

Of all cancers, lung cancer is the biggest killer in both men and women. According to the American Lung Association, it causes more deaths than colon, breast and prostate cancer combined. Diagnosing the disease can involve a number of tests, but scientists have discovered that specific compounds in exhaled breath may be used to diagnose the disease in its early stages. Read More

Breast cancer survivors benefit from yoga

Jan 28, 2014

A new US study finds that yoga can benefit breast cancer survivors by reducing fatigue and inflammation. While yoga has many components, the researchers believe breathing and meditation probably had the biggest impact. Read More

Compounds in exhaled breath may identify early lung cancer

Jan 28, 2014

Of all cancers, lung cancer is the biggest killer in both men and women. According to the American Lung Association, it causes more deaths than colon, breast and prostate cancer combined. Diagnosing the disease can involve a number of tests, but scientists have discovered that specific compounds in exhaled breath may be used to diagnose the disease in its early stages. Read More

Disrupted sleep speeds up cancer

Jan 28, 2014

Researchers in the US found of two groups of mice given the same cancer-inducing treatment, the group whose sleep was disrupted developed larger, more aggressive tumors than the well-rested mice. Read More

New classification system for breast cancers

Jan 28, 2014

Breast cancer tumors have long been classified according to their expression of three surface proteins: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2).These classifications are used to determine best treatments and prognoses, but are not adequate to describe tumor characteristics or compare them to normal breast tissue. Read More

FDA approval for CliniMACS® CD34 Reagent System for prevention of graft-versus-host disease in the treatment of acute myeloid leukemia

Jan 28, 2014

Miltenyi Biotec has announced that the U.S. Food and Drug Administration (FDA) has approved the company's CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft- versus-host disease (GVHD) in patients with acute myeloid leukemia (AML) in first complete remission undergoing allogeneic stem cell transplantation (SCT) from a matched related donor. Read More

Cracks in the cellular transport system can be key to a new generation of cancer therapies

Jan 28, 2014

Researchers from Warwick Medical School have discovered a critical point of failure in the microscopic transport system that operates inside every cell in the human body.The study, published in Nature Communications, explains how this tiny 'railway' system is a key target for cancer drugs and, as such, how this new discovery reveals how better drugs might be made. Read More

New prostate cancer model, known as RapidCaP, reveals a cancer-gene 'switch' that drives metastasis

Jan 28, 2014

Prostate cancer is the most common form of cancer in men. Affecting about 1 in 6 men, it is the second deadliest cancer. Research has been stymied by imperfect animal models of the disease, which are costly, take considerable time to develop, and fail to mimic the most lethal aspects of the illness. Read More

Large-scale analysis of over 20 tumor types increases catalog of cancer genes by 25 percent

Jan 28, 2014

A landmark study across many cancer types reveals that the universe of cancer mutations is much bigger than previously thought. By analyzing the genomes of thousands of patients' tumors, a Broad Institute-led research team has discovered many new cancer genes - expanding the list of known genes tied to these cancers by 25 percent. Read More

Previous Page   Next Page